S&P 500
(1.26%) 5 127.79 points
Dow Jones
(1.18%) 38 676 points
Nasdaq
(1.99%) 16 156 points
Oil
(-1.22%) $77.99
Gas
(5.65%) $2.15
Gold
(0.02%) $2 310.10
Silver
(-0.16%) $26.79
Platinum
(0.37%) $966.20
USD/EUR
(-0.35%) $0.929
USD/NOK
(-1.07%) $10.87
USD/GBP
(-0.11%) $0.797
USD/RUB
(0.36%) $91.45

के लिए वास्तविक समय के अद्यतन Aspen Pharmacare Holdings [APNHY]

एक्सचेंज: OTC क्षेत्र: Healthcare उद्योग: Drug Manufacturers—Specialty & Generic
अंतिम अद्यतन3 May 2024 @ 19:07

7.59% $ 12.49

Live Chart Being Loaded With Signals

Commentary (3 May 2024 @ 19:07):

Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty and branded pharmaceutical products worldwide. It operates in Commercial Pharmaceuticals and Manufacturing segments...

Stats
आज की मात्रा 109.00
औसत मात्रा 190.00
बाजार मूल्य 5.55B
Last Dividend $0.184 ( 2023-09-21 )
Next Dividend $0 ( N/A )
P/E 21.53
ATR14 $0 (0.00%)

Aspen Pharmacare Holdings सहसंबंध

10 सबसे अधिक सकारात्मक सहसंबंध
10 सबसे अधिक नकारात्मक सहसंबंध

क्या आप जानते हैं?

कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।

कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।

Aspen Pharmacare Holdings वित्तीय

Annual 2023
राजस्व: $2.29B
सकल लाभ: $1.02B (44.59 %)
EPS: $0.660
FY 2023
राजस्व: $2.29B
सकल लाभ: $1.02B (44.59 %)
EPS: $0.660
FY 2022
राजस्व: $2.54B
सकल लाभ: $1.15B (45.40 %)
EPS: $0.940
FY 2021
राजस्व: $37.77B
सकल लाभ: $17.76B (47.03 %)
EPS: $10.53

Financial Reports:

No articles found.

Aspen Pharmacare Holdings Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
$0.133
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0.184
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)

Aspen Pharmacare Holdings Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 5.17 - Stable (3.39%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend $0.101 2010-10-06
Last Dividend $0.184 2023-09-21
Next Dividend $0 N/A
Payout Date 2023-10-11
Next Payout Date N/A
# dividends 12 --
Total Paid Out $2.03 --
Avg. Dividend % Per Year 0.00% --
Score 2.69 --
Div. Sustainability Score 10.00
Div.Growth Potential Score 5.17
Div. Directional Score 7.90 --
Next Divdend (Est)
(2024-08-07)
$0.190 Estimate 3.02 %
Dividend Stability
0.24 Very Poor
Dividend Score
2.69
Pay Frequency
Sporadic
Yearly Payout
Year Amount Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for OTC

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
TELNY Ex Dividend Knight 2023-10-19 Semi-Annually 0 0.00%
HNFSA Ex Dividend Junior 2023-08-09 Quarterly 0 0.00%
ARKAY Ex Dividend Junior 2023-05-11 Annually 0 0.00%
PCLB Ex Dividend Knight 2023-09-01 Quarterly 0 0.00%
DIMC Ex Dividend Knight 2023-09-28 Quarterly 0 0.00%
UEPCO Ex Dividend Knight 2023-07-20 Quarterly 0 0.00%
JMPLY Ex Dividend Knight 2023-06-15 Semi-Annually 0 0.00%
BKHYY Ex Dividend Junior 2023-08-25 Annually 0 0.00%
RMYHY Ex Dividend Junior 2023-09-05 Semi-Annually 0 0.00%
EVSBY Ex Dividend Knight 2023-05-24 Annually 0 0.00%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.1141.5007.7210.00[0 - 0.5]
returnOnAssetsTTM0.03491.2008.8410.00[0 - 0.3]
returnOnEquityTTM0.07431.500-0.285-0.428[0.1 - 1]
payoutRatioTTM0.315-1.0006.85-6.85[0 - 1]
currentRatioTTM1.9180.8005.414.33[1 - 3]
quickRatioTTM1.0530.8008.516.81[0.8 - 2.5]
cashRatioTTM0.5051.5008.3010.00[0.2 - 2]
debtRatioTTM0.259-1.5005.68-8.52[0 - 0.6]
interestCoverageTTM88.181.00010.0010.00[3 - 30]
operatingCashFlowPerShareTTM14.112.005.3010.00[0 - 30]
freeCashFlowPerShareTTM7.622.006.1910.00[0 - 20]
debtEquityRatioTTM0.422-1.5008.31-10.00[0 - 2.5]
grossProfitMarginTTM0.4501.0005.835.83[0.2 - 0.8]
operatingProfitMarginTTM0.2001.0008.008.00[0.1 - 0.6]
cashFlowToDebtRatioTTM0.1741.000-0.146-0.146[0.2 - 2]
assetTurnoverTTM0.3070.800-1.290-1.032[0.5 - 2]
Total Score10.62

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM21.091.0007.970[1 - 100]
returnOnEquityTTM0.07432.50-0.183-0.428[0.1 - 1.5]
freeCashFlowPerShareTTM7.622.007.4610.00[0 - 30]
dividendYielPercentageTTM0.004191.5009.900[0 - 0.4]
operatingCashFlowPerShareTTM14.112.005.3010.00[0 - 30]
payoutRatioTTM0.3151.5006.85-6.85[0 - 1]
pegRatioTTM0.03561.500-3.100[0.5 - 2]
operatingCashFlowSalesRatioTTM0.1471.0008.830[0.1 - 0.5]
Total Score5.17

Aspen Pharmacare Holdings

Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty and branded pharmaceutical products worldwide. It operates in Commercial Pharmaceuticals and Manufacturing segments. The company provides general anesthetics, muscle relaxants, and topical agents under the Anaesthetics brand; and a range of injectable anticoagulants with a focus on low molecular weight heparins, Xa inhibitors, and heparin derivatives under the Thrombosis brand. It also offers branded consumer, prescription, and over-the-counter products under the regional brands, such as Circadin, Foxair, Maltofer, Mybulen, and Zyloric for various types of anesthetic comprises sleeping aid, respiratory, iron supplement, analgesic, and uric acid production inhibitor. In addition, the company manufactures and sells active pharmaceutical ingredients and finished dose form products to third-party customers. The company was founded in 1850 and is headquartered in Durban, South Africa.

के बारे में लाइव सिग्नल्स

इस पृष्ठ पर प्रस्तुत लाइव सिग्नल्स NA को कब खरीदना या बेचना है, इसका निर्धारण करने में मदद करते हैं। सिग्नल्स में 1-मिनट की देरी हो सकती है; सभी बाजार सिग्नल्स की तरह, त्रुटि या गलतियों की संभावना होती है।

लाइव ट्रेडिंग सिग्नल्स स्थायी नहीं हैं, और getagraph.com इन सिग्नल्स पर किए गए किसी भी कार्रवाई के लिए जिम्मेदारी नहीं रखते हैं, जैसा कि उपयोग की शर्तें में वर्णित है। सिग्नल्स एक व्यापक श्रृंखला के तकनीकी विश्लेषण संकेतकों पर आधारित हैं